EUVIMEDEUVIMED entdecken
Open Access

Long-Term Stability, Sterility, And Cost-Effectiveness of 0.05% Chlorhexidine Gluconate as Antisepsis for Intravitreal Injection

Asad F Durrani iD, Bita Momenaei, Viren Soni, Matthew Tennant, Jason Hsu, James Vander, Marc Spirn, Eugene Yu-Chuan Kang, Yih-Shiou Hwang, Gagan Kaushal, Sunir J Garg

Journal of Ocular Pharmacology and Therapeutics · 2024

DOI: 10.1089/jop.2024.0071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2024. Verfasst von Asad F Durrani und 10 weiteren Autor:innen. Beteiligte Einrichtung: Mid Atlantic Retina, The Retina Service of Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Chlorhexidine, Intravitreal Injections, Drug Stability, Cost-Benefit Analysis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Commercially available chlorhexidine gluconate (CHG) has a beyond-use date of 24 h. This study evaluated the stability and sterility of 0.05% CHG for 30 days after opening and compared its cost to povidone iodine (PI) for intravitreal injection antisepsis.

Methods

0.05% CHG was aliquoted into 1-mL syringes and stored at room temperature or refrigerated. Turbidity, pH, high-performance liquid chromatography (HPLC), and sterility testing were performed. A cost analysis was conducted.

Results

0.05% CHG remained stable for at least 30 days. All samples had measured turbidity

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChlorhexidineIntravitreal InjectionsDrug StabilityCost-Benefit AnalysisAnti-Infective Agents, LocalPovidone-IodineAntisepsisHumansDrug StorageTime Factors

Stichwörter der Autor:innen

chlorhexidine gluconateendophthalmitisintravitreal injectionpovidone iodine

Substanzen

Chlorhexidinechlorhexidine gluconateAnti-Infective Agents, LocalPovidone-Iodine

Autor:innen und Institutionen

  • Mid Atlantic Retina, The Retina Service of Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Department of Pharmaceutical Sciences, Jefferson College of Pharmacy, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Alberta Retina Consultants and the University of Alberta, Edmonton, Canada.
  • Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.

ORCID-Profile: Asad F Durrani

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Durrani, A. F., Momenaei, B., Soni, V., Tennant, M., Hsu, J., Vander, J., Spirn, M., Kang, E. Y., Hwang, Y. S., Kaushal, G., & Garg, S. J. (2024). Long-Term Stability, Sterility, And Cost-Effectiveness of 0.05% Chlorhexidine Gluconate as Antisepsis for Intravitreal Injection. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2024.0071

Vancouver

Durrani AF, Momenaei B, Soni V, Tennant M, Hsu J, Vander J, et al. Long-Term Stability, Sterility, And Cost-Effectiveness of 0.05% Chlorhexidine Gluconate as Antisepsis for Intravitreal Injection. Journal of Ocular Pharmacology and Therapeutics. 2024. doi:10.1089/jop.2024.0071

BibTeX
@article{Durrani2024,
  author = {Durrani, Asad F and Momenaei, Bita and Soni, Viren and Tennant, Matthew and Hsu, Jason and Vander, James and Spirn, Marc and Kang, Eugene Yu-Chuan and Hwang, Yih-Shiou and Kaushal, Gagan and Garg, Sunir J},
  title = {Long-Term Stability, Sterility, And Cost-Effectiveness of 0.05% Chlorhexidine Gluconate as Antisepsis for Intravitreal Injection},
  journal = {Journal of Ocular Pharmacology and Therapeutics},
  year = {2024},
  doi = {10.1089/jop.2024.0071}
}
Kostenlos starten →